£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Hormone-Drug Breast Cancer Therapeutics in the United States

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days · 1 data points (no recent data)

Historical
Generating forecast…
Not enough data points to display chart (need at least 2 points)
View at Amazon ↗

Price data last checked 75 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price
1 day 0 0 1 1 1 £520 Days at Price

Price Analysis

Most common price: £520 (1 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 1 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Hormone-Drug Breast Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Hormone-Drug Breast Cancer Therapeutics in India

£515.00 06 Sep 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in the United States
95% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Oligonucleotide Therapeutics in the United States
95% match

The 2023-2028 Outlook for Oligonucleotide Therapeutics in the United States

£520.00 13 Nov 2026
The 2023-2028 Outlook for Menopausal Hot Flashes Therapies in the United States
95% match

The 2023-2028 Outlook for Menopausal Hot Flashes Therapies in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Life Science Products in the United States
94% match

The 2023-2028 Outlook for Life Science Products in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Women's Health Care in the United States
94% match

The 2023-2028 Outlook for Women's Health Care in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Oral Anti Diabetes Drugs in the United States
94% match

The 2023-2028 Outlook for Oral Anti Diabetes Drugs in the United States

£520.00 26 Oct 2026
The 2023-2028 Outlook for Pain Relief Therapies in the United States
94% match

The 2023-2028 Outlook for Pain Relief Therapies in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Depression Drugs in the United States
94% match

The 2023-2028 Outlook for Depression Drugs in the United States

£520.00 27 Oct 2026
The 2023-2028 Outlook for Companion Animal Drugs in the United States
94% match

The 2023-2028 Outlook for Companion Animal Drugs in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Non-Melanoma Skin Cancers in the United States
94% match

The 2023-2028 Outlook for Non-Melanoma Skin Cancers in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Red Biotechnologies in the United States
94% match

The 2023-2028 Outlook for Red Biotechnologies in the United States

£520.00 15 Nov 2026
The 2023-2028 Outlook for Cold Laser Therapies in the United States
94% match

The 2023-2028 Outlook for Cold Laser Therapies in the United States

£520.00 17 Nov 2026
The 2023-2028 Outlook for Lipids in the United States
94% match

The 2023-2028 Outlook for Lipids in the United States

£520.00 16 Oct 2026
The 2023-2028 Outlook for Children's Digestion Medicines in the United States
94% match

The 2023-2028 Outlook for Children's Digestion Medicines in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Organ Transplant Immunosuppressants in the United States
94% match

The 2023-2028 Outlook for Organ Transplant Immunosuppressants in the United States

£520.00 26 Oct 2026
The 2023-2028 Outlook for Peripheral Vascular Devices in the United States
93% match

The 2023-2028 Outlook for Peripheral Vascular Devices in the United States

£520.00 16 Oct 2026
The 2023-2028 Outlook for Oligonucleotide Therapeutics in India
93% match

The 2023-2028 Outlook for Oligonucleotide Therapeutics in India

£515.00 21 Oct 2026
The 2023-2028 Outlook for Aesthetics Combination Therapies in the United States
93% match

The 2023-2028 Outlook for Aesthetics Combination Therapies in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Osteoarthritis Treatments in the United States
93% match

The 2023-2028 Outlook for Osteoarthritis Treatments in the United States

£520.00 06 Sep 2026
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments in the United States
93% match

The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments in the United States

£520.00 15 Oct 2026
The 2023-2028 Outlook for Tobacco Products in the United States
93% match

The 2023-2028 Outlook for Tobacco Products in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Sports Medicine Devices in the United States
93% match

The 2023-2028 Outlook for Sports Medicine Devices in the United States

£520.00 14 Nov 2026
The 2023-2028 Outlook for Cosmetic Lasers in the United States
93% match

The 2023-2028 Outlook for Cosmetic Lasers in the United States

£520.00 20 Oct 2026